Blog
[printfriendly]
-
Aug 1, 2011
DARA BioSciences Receives Fast Track Designation from FDA for Treatment of Chemotherapy-Induced Neuropathic Pain in Patients with Cancer
In a program designed to facilitate the development and expedite the review of new drugs, the FDA created the Fast Track program. DARA BioSciences has been awarded the Fast Track… -
Jun 1, 2011
Genetic Clue to Painful Peripheral Neuropathy
A study published in the Annals of Neurology indicates that a single gene may be responsible for the pain suffered in many people with a type of peripheral neuropathy that… -
Jun 1, 2011
Source of Mystery Pain Uncovered
For the 20 million Americans suffering with PN, there is no good treatment for the disorder and doctors can find no apparent cause in one of every three cases. An… -
Jun 1, 2011
Hopkins Research Suggests that Blood Vessels and Support Cells may be Real Targets of Treatment for Diabetic Nerve Damage
Blood vessels and supporting cells appear to be pivotal partners in repairing nerves ravagedby diabetic neuropathy, and nurturing their partnership with nerve cells might make the difference between success and… -
May 1, 2011
High Triglycerides Increase Risk of Neuropathy for Patients with HIV
In a study conducted by Dr. Sugato Banerjee of the HIV Neurobehavioral Research Center in San Diego and his colleagues a potential connection has been found between elevated lipid levels… -
May 1, 2011
Capsaicin Patch Eases HIV Neuropathy Pain
In a report presented at the American Academy of Pain Medicine, Dr. Stephen J. Brown, states that difficult to treat HIV-associated neuropathic pain appears to be eased for at least… -
May 1, 2011
Genetic Biomarker Predicts Taxane-induced Neuropathy
A new study has identified the first genetic biomarkers for taxane-induced peripheral neuropathy, a potentially severe complication of taxane chemotherapy. Dr. Bryan Schneider, lead author and a physician/researcher at the… -
May 1, 2011
Genetic Test Could Predict When Myeloma Drugs Will Cause PN
The Institute of Cancer Research (ICR) has published a new study stating that a genetic test has been found that predicts whether bone marrow cancer treatments, including thalidomide, are likely…